COVID-19 Impact on Global Ophthalmol Drug, Market Insights and Forecast to 2026
Ophthalmol Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmol Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ophthalmol Drug market is segmented into
The Ophthalmol Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmol Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ophthalmol Drug Market Share Analysis
Ophthalmol Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmol Drug business, the date to enter into the Ophthalmol Drug market, Ophthalmol Drug product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Ophthalmol Drug market is segmented into
- Retinal disorders drugs
- Allergic, inflammatory and infective drugs
- Glaucoma drugs
- Dry eye drugs
- Glaucoma
- Dry eye syndrome
- Retinal diseases
- Other ophthalmic indications
The Ophthalmol Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmol Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ophthalmol Drug Market Share Analysis
Ophthalmol Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmol Drug business, the date to enter into the Ophthalmol Drug market, Ophthalmol Drug product introduction, recent developments, etc.
The major vendors covered:
- Novartis
- Allergan
- Roche
- Valeant
- Regeneron
- Santen
- Bayer
- Pfizer
- Senju
- Akorn
1 STUDY COVERAGE
1.1 Ophthalmol Drug Product Introduction
1.2 Market Segments
1.3 Key Ophthalmol Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ophthalmol Drug Market Size Growth Rate by Type
1.4.2 Retinal disorders drugs
1.4.3 Allergic, inflammatory and infective drugs
1.4.4 Glaucoma drugs
1.4.5 Dry eye drugs
1.5 Market by Application
1.5.1 Global Ophthalmol Drug Market Size Growth Rate by Application
1.5.2 Glaucoma
1.5.3 Dry eye syndrome
1.5.4 Retinal diseases
1.5.5 Other ophthalmic indications
1.6 Coronavirus Disease 2019 (Covid-19): Ophthalmol Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Ophthalmol Drug Industry
1.6.1.1 Ophthalmol Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Ophthalmol Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Ophthalmol Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Ophthalmol Drug Market Size Estimates and Forecasts
2.1.1 Global Ophthalmol Drug Revenue 2015-2026
2.1.2 Global Ophthalmol Drug Sales 2015-2026
2.2 Ophthalmol Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Ophthalmol Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ophthalmol Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OPHTHALMOL DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Ophthalmol Drug Sales by Manufacturers
3.1.1 Ophthalmol Drug Sales by Manufacturers (2015-2020)
3.1.2 Ophthalmol Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Ophthalmol Drug Revenue by Manufacturers
3.2.1 Ophthalmol Drug Revenue by Manufacturers (2015-2020)
3.2.2 Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ophthalmol Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ophthalmol Drug Revenue in 2019
3.2.5 Global Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ophthalmol Drug Price by Manufacturers
3.4 Ophthalmol Drug Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmol Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmol Drug Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmol Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Ophthalmol Drug Market Size by Type (2015-2020)
4.1.1 Global Ophthalmol Drug Sales by Type (2015-2020)
4.1.2 Global Ophthalmol Drug Revenue by Type (2015-2020)
4.1.3 Ophthalmol Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ophthalmol Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Ophthalmol Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Ophthalmol Drug Revenue Forecast by Type (2021-2026)
4.2.3 Ophthalmol Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ophthalmol Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Ophthalmol Drug Market Size by Application (2015-2020)
5.1.1 Global Ophthalmol Drug Sales by Application (2015-2020)
5.1.2 Global Ophthalmol Drug Revenue by Application (2015-2020)
5.1.3 Ophthalmol Drug Price by Application (2015-2020)
5.2 Ophthalmol Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Ophthalmol Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Ophthalmol Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Ophthalmol Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Ophthalmol Drug by Country
6.1.1 North America Ophthalmol Drug Sales by Country
6.1.2 North America Ophthalmol Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ophthalmol Drug Market Facts & Figures by Type
6.3 North America Ophthalmol Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Ophthalmol Drug by Country
7.1.1 Europe Ophthalmol Drug Sales by Country
7.1.2 Europe Ophthalmol Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmol Drug Market Facts & Figures by Type
7.3 Europe Ophthalmol Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Ophthalmol Drug by Region
8.1.1 Asia Pacific Ophthalmol Drug Sales by Region
8.1.2 Asia Pacific Ophthalmol Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ophthalmol Drug Market Facts & Figures by Type
8.3 Asia Pacific Ophthalmol Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Ophthalmol Drug by Country
9.1.1 Latin America Ophthalmol Drug Sales by Country
9.1.2 Latin America Ophthalmol Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ophthalmol Drug Market Facts & Figures by Type
9.3 Central & South America Ophthalmol Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Ophthalmol Drug by Country
10.1.1 Middle East and Africa Ophthalmol Drug Sales by Country
10.1.2 Middle East and Africa Ophthalmol Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Type
10.3 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Ophthalmol Drug Products Offered
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description, Business Overview and Total Revenue
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Ophthalmol Drug Products Offered
11.2.5 Allergan Recent Development
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description, Business Overview and Total Revenue
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Ophthalmol Drug Products Offered
11.3.5 Roche Recent Development
11.4 Valeant
11.4.1 Valeant Corporation Information
11.4.2 Valeant Description, Business Overview and Total Revenue
11.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Valeant Ophthalmol Drug Products Offered
11.4.5 Valeant Recent Development
11.5 Regeneron
11.5.1 Regeneron Corporation Information
11.5.2 Regeneron Description, Business Overview and Total Revenue
11.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regeneron Ophthalmol Drug Products Offered
11.5.5 Regeneron Recent Development
11.6 Santen
11.6.1 Santen Corporation Information
11.6.2 Santen Description, Business Overview and Total Revenue
11.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Santen Ophthalmol Drug Products Offered
11.6.5 Santen Recent Development
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Description, Business Overview and Total Revenue
11.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bayer Ophthalmol Drug Products Offered
11.7.5 Bayer Recent Development
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description, Business Overview and Total Revenue
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Ophthalmol Drug Products Offered
11.8.5 Pfizer Recent Development
11.9 Senju
11.9.1 Senju Corporation Information
11.9.2 Senju Description, Business Overview and Total Revenue
11.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Senju Ophthalmol Drug Products Offered
11.9.5 Senju Recent Development
11.10 Akorn
11.10.1 Akorn Corporation Information
11.10.2 Akorn Description, Business Overview and Total Revenue
11.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Akorn Ophthalmol Drug Products Offered
11.10.5 Akorn Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Ophthalmol Drug Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Ophthalmol Drug Market Estimates and Projections by Region
12.1.1 Global Ophthalmol Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Ophthalmol Drug Revenue Forecast by Regions 2021-2026
12.2 North America Ophthalmol Drug Market Size Forecast (2021-2026)
12.2.1 North America: Ophthalmol Drug Sales Forecast (2021-2026)
12.2.2 North America: Ophthalmol Drug Revenue Forecast (2021-2026)
12.2.3 North America: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Ophthalmol Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Ophthalmol Drug Sales Forecast (2021-2026)
12.3.2 Europe: Ophthalmol Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ophthalmol Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ophthalmol Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ophthalmol Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ophthalmol Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Ophthalmol Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Ophthalmol Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Ophthalmol Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ophthalmol Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ophthalmol Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ophthalmol Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ophthalmol Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Ophthalmol Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Ophthalmol Drug Product Introduction
1.2 Market Segments
1.3 Key Ophthalmol Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ophthalmol Drug Market Size Growth Rate by Type
1.4.2 Retinal disorders drugs
1.4.3 Allergic, inflammatory and infective drugs
1.4.4 Glaucoma drugs
1.4.5 Dry eye drugs
1.5 Market by Application
1.5.1 Global Ophthalmol Drug Market Size Growth Rate by Application
1.5.2 Glaucoma
1.5.3 Dry eye syndrome
1.5.4 Retinal diseases
1.5.5 Other ophthalmic indications
1.6 Coronavirus Disease 2019 (Covid-19): Ophthalmol Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Ophthalmol Drug Industry
1.6.1.1 Ophthalmol Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Ophthalmol Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Ophthalmol Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Ophthalmol Drug Market Size Estimates and Forecasts
2.1.1 Global Ophthalmol Drug Revenue 2015-2026
2.1.2 Global Ophthalmol Drug Sales 2015-2026
2.2 Ophthalmol Drug Market Size by Region: 2020 Versus 2026
2.2.1 Global Ophthalmol Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ophthalmol Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OPHTHALMOL DRUG COMPETITOR LANDSCAPE BY PLAYERS
3.1 Ophthalmol Drug Sales by Manufacturers
3.1.1 Ophthalmol Drug Sales by Manufacturers (2015-2020)
3.1.2 Ophthalmol Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Ophthalmol Drug Revenue by Manufacturers
3.2.1 Ophthalmol Drug Revenue by Manufacturers (2015-2020)
3.2.2 Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ophthalmol Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ophthalmol Drug Revenue in 2019
3.2.5 Global Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ophthalmol Drug Price by Manufacturers
3.4 Ophthalmol Drug Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmol Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmol Drug Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmol Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Ophthalmol Drug Market Size by Type (2015-2020)
4.1.1 Global Ophthalmol Drug Sales by Type (2015-2020)
4.1.2 Global Ophthalmol Drug Revenue by Type (2015-2020)
4.1.3 Ophthalmol Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ophthalmol Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Ophthalmol Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Ophthalmol Drug Revenue Forecast by Type (2021-2026)
4.2.3 Ophthalmol Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ophthalmol Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Ophthalmol Drug Market Size by Application (2015-2020)
5.1.1 Global Ophthalmol Drug Sales by Application (2015-2020)
5.1.2 Global Ophthalmol Drug Revenue by Application (2015-2020)
5.1.3 Ophthalmol Drug Price by Application (2015-2020)
5.2 Ophthalmol Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Ophthalmol Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Ophthalmol Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Ophthalmol Drug Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Ophthalmol Drug by Country
6.1.1 North America Ophthalmol Drug Sales by Country
6.1.2 North America Ophthalmol Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ophthalmol Drug Market Facts & Figures by Type
6.3 North America Ophthalmol Drug Market Facts & Figures by Application
7 EUROPE
7.1 Europe Ophthalmol Drug by Country
7.1.1 Europe Ophthalmol Drug Sales by Country
7.1.2 Europe Ophthalmol Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmol Drug Market Facts & Figures by Type
7.3 Europe Ophthalmol Drug Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Ophthalmol Drug by Region
8.1.1 Asia Pacific Ophthalmol Drug Sales by Region
8.1.2 Asia Pacific Ophthalmol Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ophthalmol Drug Market Facts & Figures by Type
8.3 Asia Pacific Ophthalmol Drug Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Ophthalmol Drug by Country
9.1.1 Latin America Ophthalmol Drug Sales by Country
9.1.2 Latin America Ophthalmol Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ophthalmol Drug Market Facts & Figures by Type
9.3 Central & South America Ophthalmol Drug Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Ophthalmol Drug by Country
10.1.1 Middle East and Africa Ophthalmol Drug Sales by Country
10.1.2 Middle East and Africa Ophthalmol Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Type
10.3 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Ophthalmol Drug Products Offered
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description, Business Overview and Total Revenue
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Ophthalmol Drug Products Offered
11.2.5 Allergan Recent Development
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description, Business Overview and Total Revenue
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Ophthalmol Drug Products Offered
11.3.5 Roche Recent Development
11.4 Valeant
11.4.1 Valeant Corporation Information
11.4.2 Valeant Description, Business Overview and Total Revenue
11.4.3 Valeant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Valeant Ophthalmol Drug Products Offered
11.4.5 Valeant Recent Development
11.5 Regeneron
11.5.1 Regeneron Corporation Information
11.5.2 Regeneron Description, Business Overview and Total Revenue
11.5.3 Regeneron Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Regeneron Ophthalmol Drug Products Offered
11.5.5 Regeneron Recent Development
11.6 Santen
11.6.1 Santen Corporation Information
11.6.2 Santen Description, Business Overview and Total Revenue
11.6.3 Santen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Santen Ophthalmol Drug Products Offered
11.6.5 Santen Recent Development
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Description, Business Overview and Total Revenue
11.7.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bayer Ophthalmol Drug Products Offered
11.7.5 Bayer Recent Development
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description, Business Overview and Total Revenue
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Ophthalmol Drug Products Offered
11.8.5 Pfizer Recent Development
11.9 Senju
11.9.1 Senju Corporation Information
11.9.2 Senju Description, Business Overview and Total Revenue
11.9.3 Senju Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Senju Ophthalmol Drug Products Offered
11.9.5 Senju Recent Development
11.10 Akorn
11.10.1 Akorn Corporation Information
11.10.2 Akorn Description, Business Overview and Total Revenue
11.10.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Akorn Ophthalmol Drug Products Offered
11.10.5 Akorn Recent Development
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description, Business Overview and Total Revenue
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis Ophthalmol Drug Products Offered
11.1.5 Novartis Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Ophthalmol Drug Market Estimates and Projections by Region
12.1.1 Global Ophthalmol Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Ophthalmol Drug Revenue Forecast by Regions 2021-2026
12.2 North America Ophthalmol Drug Market Size Forecast (2021-2026)
12.2.1 North America: Ophthalmol Drug Sales Forecast (2021-2026)
12.2.2 North America: Ophthalmol Drug Revenue Forecast (2021-2026)
12.2.3 North America: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Ophthalmol Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Ophthalmol Drug Sales Forecast (2021-2026)
12.3.2 Europe: Ophthalmol Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ophthalmol Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ophthalmol Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ophthalmol Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ophthalmol Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Ophthalmol Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Ophthalmol Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Ophthalmol Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ophthalmol Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ophthalmol Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ophthalmol Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ophthalmol Drug Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ophthalmol Drug Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Ophthalmol Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Ophthalmol Drug Market Segments
Table 2. Ranking of Global Top Ophthalmol Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ophthalmol Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Retinal disorders drugs
Table 5. Major Manufacturers of Allergic, inflammatory and infective drugs
Table 6. Major Manufacturers of Glaucoma drugs
Table 7. Major Manufacturers of Dry eye drugs
Table 8. COVID-19 Impact Global Market: (Four Ophthalmol Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Ophthalmol Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Ophthalmol Drug Players to Combat Covid-19 Impact
Table 13. Global Ophthalmol Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Ophthalmol Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Ophthalmol Drug Sales by Regions 2015-2020 (K MT)
Table 16. Global Ophthalmol Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Ophthalmol Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Ophthalmol Drug Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Ophthalmol Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Ophthalmol Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Ophthalmol Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmol Drug as of 2019)
Table 22. Ophthalmol Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Ophthalmol Drug Price (2015-2020) (USD/MT)
Table 25. Ophthalmol Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Ophthalmol Drug Product Type
Table 27. Date of International Manufacturers Enter into Ophthalmol Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 30. Global Ophthalmol Drug Sales Share by Type (2015-2020)
Table 31. Global Ophthalmol Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Ophthalmol Drug Revenue Share by Type (2015-2020)
Table 33. Ophthalmol Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 35. Global Ophthalmol Drug Sales Share by Application (2015-2020)
Table 36. North America Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 37. North America Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 38. North America Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 41. North America Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 42. North America Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 43. North America Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 45. Europe Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 49. Europe Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 51. Europe Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Ophthalmol Drug Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Ophthalmol Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Ophthalmol Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Ophthalmol Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 61. Latin America Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 65. Latin America Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 67. Latin America Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 76. Novartis Corporation Information
Table 77. Novartis Description and Major Businesses
Table 78. Novartis Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Novartis Product
Table 80. Novartis Recent Development
Table 81. Allergan Corporation Information
Table 82. Allergan Description and Major Businesses
Table 83. Allergan Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Allergan Product
Table 85. Allergan Recent Development
Table 86. Roche Corporation Information
Table 87. Roche Description and Major Businesses
Table 88. Roche Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Roche Product
Table 90. Roche Recent Development
Table 91. Valeant Corporation Information
Table 92. Valeant Description and Major Businesses
Table 93. Valeant Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Valeant Product
Table 95. Valeant Recent Development
Table 96. Regeneron Corporation Information
Table 97. Regeneron Description and Major Businesses
Table 98. Regeneron Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Regeneron Product
Table 100. Regeneron Recent Development
Table 101. Santen Corporation Information
Table 102. Santen Description and Major Businesses
Table 103. Santen Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Santen Product
Table 105. Santen Recent Development
Table 106. Bayer Corporation Information
Table 107. Bayer Description and Major Businesses
Table 108. Bayer Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Bayer Product
Table 110. Bayer Recent Development
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Pfizer Product
Table 115. Pfizer Recent Development
Table 116. Senju Corporation Information
Table 117. Senju Description and Major Businesses
Table 118. Senju Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Senju Product
Table 120. Senju Recent Development
Table 121. Akorn Corporation Information
Table 122. Akorn Description and Major Businesses
Table 123. Akorn Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Akorn Product
Table 125. Akorn Recent Development
Table 126. Global Ophthalmol Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 127. Global Ophthalmol Drug Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Ophthalmol Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Ophthalmol Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 131. North America: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 133. Europe: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Ophthalmol Drug Sales Forecast by Region (2021-2026) (K MT)
Table 135. Asia Pacific: Ophthalmol Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 137. Latin America: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 139. Middle East and Africa: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Ophthalmol Drug Players
Table 144. Ophthalmol Drug Customers List
Table 145. Ophthalmol Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 1. Ophthalmol Drug Market Segments
Table 2. Ranking of Global Top Ophthalmol Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ophthalmol Drug Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Retinal disorders drugs
Table 5. Major Manufacturers of Allergic, inflammatory and infective drugs
Table 6. Major Manufacturers of Glaucoma drugs
Table 7. Major Manufacturers of Dry eye drugs
Table 8. COVID-19 Impact Global Market: (Four Ophthalmol Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Ophthalmol Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Ophthalmol Drug Players to Combat Covid-19 Impact
Table 13. Global Ophthalmol Drug Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Ophthalmol Drug Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Ophthalmol Drug Sales by Regions 2015-2020 (K MT)
Table 16. Global Ophthalmol Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Ophthalmol Drug Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Ophthalmol Drug Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Ophthalmol Drug Sales Share by Manufacturers (2015-2020)
Table 20. Global Ophthalmol Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Ophthalmol Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmol Drug as of 2019)
Table 22. Ophthalmol Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Ophthalmol Drug Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Ophthalmol Drug Price (2015-2020) (USD/MT)
Table 25. Ophthalmol Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Ophthalmol Drug Product Type
Table 27. Date of International Manufacturers Enter into Ophthalmol Drug Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 30. Global Ophthalmol Drug Sales Share by Type (2015-2020)
Table 31. Global Ophthalmol Drug Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Ophthalmol Drug Revenue Share by Type (2015-2020)
Table 33. Ophthalmol Drug Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 35. Global Ophthalmol Drug Sales Share by Application (2015-2020)
Table 36. North America Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 37. North America Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 38. North America Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 40. North America Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 41. North America Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 42. North America Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 43. North America Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 44. Europe Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 45. Europe Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 46. Europe Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 48. Europe Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 49. Europe Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 50. Europe Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 51. Europe Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Ophthalmol Drug Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Ophthalmol Drug Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Ophthalmol Drug Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Ophthalmol Drug Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 60. Latin America Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 61. Latin America Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 64. Latin America Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 65. Latin America Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 66. Latin America Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 67. Latin America Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Ophthalmol Drug Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Ophthalmol Drug Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Ophthalmol Drug Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Ophthalmol Drug Sales Market Share by Application (2015-2020)
Table 76. Novartis Corporation Information
Table 77. Novartis Description and Major Businesses
Table 78. Novartis Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Novartis Product
Table 80. Novartis Recent Development
Table 81. Allergan Corporation Information
Table 82. Allergan Description and Major Businesses
Table 83. Allergan Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Allergan Product
Table 85. Allergan Recent Development
Table 86. Roche Corporation Information
Table 87. Roche Description and Major Businesses
Table 88. Roche Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Roche Product
Table 90. Roche Recent Development
Table 91. Valeant Corporation Information
Table 92. Valeant Description and Major Businesses
Table 93. Valeant Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Valeant Product
Table 95. Valeant Recent Development
Table 96. Regeneron Corporation Information
Table 97. Regeneron Description and Major Businesses
Table 98. Regeneron Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Regeneron Product
Table 100. Regeneron Recent Development
Table 101. Santen Corporation Information
Table 102. Santen Description and Major Businesses
Table 103. Santen Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Santen Product
Table 105. Santen Recent Development
Table 106. Bayer Corporation Information
Table 107. Bayer Description and Major Businesses
Table 108. Bayer Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Bayer Product
Table 110. Bayer Recent Development
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Pfizer Product
Table 115. Pfizer Recent Development
Table 116. Senju Corporation Information
Table 117. Senju Description and Major Businesses
Table 118. Senju Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Senju Product
Table 120. Senju Recent Development
Table 121. Akorn Corporation Information
Table 122. Akorn Description and Major Businesses
Table 123. Akorn Ophthalmol Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Akorn Product
Table 125. Akorn Recent Development
Table 126. Global Ophthalmol Drug Sales Forecast by Regions (2021-2026) (K MT)
Table 127. Global Ophthalmol Drug Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Ophthalmol Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Ophthalmol Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 131. North America: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 133. Europe: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Ophthalmol Drug Sales Forecast by Region (2021-2026) (K MT)
Table 135. Asia Pacific: Ophthalmol Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 137. Latin America: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Ophthalmol Drug Sales Forecast by Country (2021-2026) (K MT)
Table 139. Middle East and Africa: Ophthalmol Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Ophthalmol Drug Players
Table 144. Ophthalmol Drug Customers List
Table 145. Ophthalmol Drug Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Ophthalmol Drug Product Picture
Figure 2. Global Ophthalmol Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Retinal disorders drugs Product Picture
Figure 4. Allergic, inflammatory and infective drugs Product Picture
Figure 5. Glaucoma drugs Product Picture
Figure 6. Dry eye drugs Product Picture
Figure 7. Global Ophthalmol Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Glaucoma
Figure 9. Dry eye syndrome
Figure 10. Retinal diseases
Figure 11. Other ophthalmic indications
Figure 12. Ophthalmol Drug Report Years Considered
Figure 13. Global Ophthalmol Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Ophthalmol Drug Sales 2015-2026 (K MT)
Figure 15. Global Ophthalmol Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Ophthalmol Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Ophthalmol Drug Sales Market Share by Region in 2019
Figure 18. Global Ophthalmol Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Ophthalmol Drug Revenue Market Share by Region in 2019
Figure 20. Global Ophthalmol Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Ophthalmol Drug Revenue in 2019
Figure 22. Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Ophthalmol Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Ophthalmol Drug Sales Market Share by Type in 2019
Figure 25. Global Ophthalmol Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Ophthalmol Drug Revenue Market Share by Type in 2019
Figure 27. Global Ophthalmol Drug Market Share by Price Range (2015-2020)
Figure 28. Global Ophthalmol Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Ophthalmol Drug Sales Market Share by Application in 2019
Figure 30. Global Ophthalmol Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Ophthalmol Drug Revenue Market Share by Application in 2019
Figure 32. North America Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Ophthalmol Drug Sales Market Share by Country in 2019
Figure 35. North America Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Ophthalmol Drug Market Share by Type in 2019
Figure 41. North America Ophthalmol Drug Market Share by Application in 2019
Figure 42. Europe Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Ophthalmol Drug Sales Market Share by Country in 2019
Figure 45. Europe Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 46. Germany Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Ophthalmol Drug Market Share by Type in 2019
Figure 57. Europe Ophthalmol Drug Market Share by Application in 2019
Figure 58. Asia Pacific Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Ophthalmol Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Ophthalmol Drug Revenue Market Share by Region in 2019
Figure 62. China Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Ophthalmol Drug Market Share by Type in 2019
Figure 85. Asia Pacific Ophthalmol Drug Market Share by Application in 2019
Figure 86. Latin America Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Ophthalmol Drug Sales Market Share by Country in 2019
Figure 89. Latin America Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Ophthalmol Drug Market Share by Type in 2019
Figure 97. Latin America Ophthalmol Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Ophthalmol Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Ophthalmol Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Ophthalmol Drug Market Share by Application in 2019
Figure 110. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Senju Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. North America Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Europe Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Asia Pacific Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Latin America Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Middle East and Africa Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
Figure 1. Ophthalmol Drug Product Picture
Figure 2. Global Ophthalmol Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Retinal disorders drugs Product Picture
Figure 4. Allergic, inflammatory and infective drugs Product Picture
Figure 5. Glaucoma drugs Product Picture
Figure 6. Dry eye drugs Product Picture
Figure 7. Global Ophthalmol Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Glaucoma
Figure 9. Dry eye syndrome
Figure 10. Retinal diseases
Figure 11. Other ophthalmic indications
Figure 12. Ophthalmol Drug Report Years Considered
Figure 13. Global Ophthalmol Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Ophthalmol Drug Sales 2015-2026 (K MT)
Figure 15. Global Ophthalmol Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Ophthalmol Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Ophthalmol Drug Sales Market Share by Region in 2019
Figure 18. Global Ophthalmol Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Ophthalmol Drug Revenue Market Share by Region in 2019
Figure 20. Global Ophthalmol Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Ophthalmol Drug Revenue in 2019
Figure 22. Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Ophthalmol Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Ophthalmol Drug Sales Market Share by Type in 2019
Figure 25. Global Ophthalmol Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Ophthalmol Drug Revenue Market Share by Type in 2019
Figure 27. Global Ophthalmol Drug Market Share by Price Range (2015-2020)
Figure 28. Global Ophthalmol Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Ophthalmol Drug Sales Market Share by Application in 2019
Figure 30. Global Ophthalmol Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Ophthalmol Drug Revenue Market Share by Application in 2019
Figure 32. North America Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Ophthalmol Drug Sales Market Share by Country in 2019
Figure 35. North America Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Ophthalmol Drug Market Share by Type in 2019
Figure 41. North America Ophthalmol Drug Market Share by Application in 2019
Figure 42. Europe Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Ophthalmol Drug Sales Market Share by Country in 2019
Figure 45. Europe Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 46. Germany Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Ophthalmol Drug Market Share by Type in 2019
Figure 57. Europe Ophthalmol Drug Market Share by Application in 2019
Figure 58. Asia Pacific Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Ophthalmol Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Ophthalmol Drug Revenue Market Share by Region in 2019
Figure 62. China Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Ophthalmol Drug Market Share by Type in 2019
Figure 85. Asia Pacific Ophthalmol Drug Market Share by Application in 2019
Figure 86. Latin America Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Ophthalmol Drug Sales Market Share by Country in 2019
Figure 89. Latin America Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Ophthalmol Drug Market Share by Type in 2019
Figure 97. Latin America Ophthalmol Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Ophthalmol Drug Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Ophthalmol Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Ophthalmol Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Ophthalmol Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Ophthalmol Drug Market Share by Application in 2019
Figure 110. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Senju Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. North America Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Europe Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Asia Pacific Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Latin America Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Ophthalmol Drug Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Middle East and Africa Ophthalmol Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
Figure 134. Data Triangulation
Figure 135. Key Executives Interviewed
